drugset / Trial / NCT00098020

Podocyte Retinoids

NCT00098020

NaSingle-groupOpen-labelTreatment

Summary

This is a pilot study of retinoids for patients with unsatisfactory response to conventional treatment of nephrotic syndrome due to focal segmental glomerulosclerosis or minimal change disease, two renal disorders associated with putatively pathogenic malfunctioning of glomerular podocytes. The hypothesis that retinoids may have reparative effects on these cells is based on previous research showing that retinoids promote the differentiation or redifferentiation of aberrant epithelial cells. Results obtained by 6 months of treatment with retinoids (that have been approved for non-renal indications) will be used as preliminary information upon which to base further testing of these agents in formal clinical trials in refractory cases of these nephrotic syndromes.

Timeline

Start
2004-11-26
Primary completion
2016-06-27
Completion
2016-06-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Isotretinoin Other / unclassified